About Sreejayan Nair
Form D filings for WiTii Pharmaceuticals in 2024 list Sreejayan Nair as director.
Sreejayan Nair first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Sreejayan Nair in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sreejayan Nair works with at each company, as listed on that company's latest Form D.
WiTii Pharmaceuticals, Inc. · Form D, Jul 11, 2024
AS
Anand Shukla
President and director